Delivery Order SPE2DR25D1017-SPE2DR26F8YNE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,282.52 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orencia 125 mg/ml syringes. This firm fixed-price delivery order, which is expected to be completed by September 9, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio for federal medical procurement. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,522.89 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on October 17, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Orencia 125 mg/mL syringes valued at $7,796.46. This non-competitive delivery order is issued under a firm fixed price structure with a completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued against AmerisourceBergen's Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,711.89 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orencia 125 mg/ml syringes. The contract carries a firm fixed price structure with no set-aside designation, reflecting competitive procurement procedures. The award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Orencia 125 mg/mL syringes valued at $14,877.38. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement standards. The contract is performed from...
- The Defense Logistics Agency awarded a $70,485.61 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Orencia 125 mg/ml syringes. This competitively awarded, firm fixed-price contract has an ultimate completion date of October 23, 2025, and carries no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $46,654.02 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/mL syringes. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orencia 125 mg/ml syringes with a ceiling value of $8,140.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is expected to be completed by July 23, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $5,372.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order for pharmaceutical supply under the company's existing federal contracting vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, supplying the...
- The Defense Logistics Agency awarded a $32,269.35 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes, with an ultimate completion date of October 23, 2025. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8YNEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Orencia 125 mg/ml syringes valued at $8,000.63. This non-competitive, firm fixed-price delivery order is set to be completed by October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government's defense and military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to meet federal medical procurement requirements through competitive award processes, providing medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 10/27/25 |